BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37770853)

  • 21. Long non-coding RNA titin-antisense RNA1 contributes to growth and metastasis of cholangiocarcinoma by suppressing microRNA-513a-5p to upregulate stratifin.
    Liu Y; Sun J; Qi P; Liu Y
    Bioengineered; 2021 Dec; 12(2):12611-12624. PubMed ID: 34903127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells.
    Qin X; Lu M; Zhou Y; Li G; Liu Z
    Cell Cycle; 2019 Apr; 18(8):889-897. PubMed ID: 30983519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SP1 induced long non-coding RNA AGAP2-AS1 promotes cholangiocarcinoma proliferation via silencing of CDKN1A.
    Ji H; Wang J; Lu B; Li J; Zhou J; Wang L; Xu S; Peng P; Hu X; Wang K
    Mol Med; 2021 Feb; 27(1):10. PubMed ID: 33522895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p.
    Li J; Guan C; Hu Z; Liu L; Su Z; Kang P; Jiang X; Cui Y
    Hum Cell; 2021 Jan; 34(1):187-200. PubMed ID: 33040228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
    Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
    Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. lncRNA TM4SF1-AS1 predicts dismal outcomes and promotes cholangiocarcinoma progression via modulating miR-744-3p.
    Jiang H; Li W; Xue Z; Chen W; Zhao L; Song H; Hou J
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101915. PubMed ID: 35346892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating tumor cell-derived exosome-transmitted long non-coding RNA TTN-AS1 can promote the proliferation and migration of cholangiocarcinoma cells.
    Zhou X; Kong X; Lu J; Wang H; Liu M; Zhao S; Xia Z; Liu Q; Sun H; Gao X; Ma C; Niu Z; Yang F; Song X; Gao H; Zhang S; Zhu H
    J Nanobiotechnology; 2024 Apr; 22(1):191. PubMed ID: 38637832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis.
    Sun ZP; Tan ZG; Peng C; Yi WM
    J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis.
    Lei S; Cao W; Zeng Z; Zhang Z; Jin B; Tian Q; Wu Y; Zhang T; Li D; Hu C; Lan J; Zhang J; Chen T
    Cell Death Dis; 2022 Nov; 13(11):967. PubMed ID: 36400758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
    Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
    Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
    Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
    Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a prognosis-related ceRNA network in cholangiocarcinoma and potentially therapeutic molecules using a bioinformatic approach and molecular docking.
    Gao X; Zhang W; Jia Y; Xu H; Zhu Y; Pei X
    Sci Rep; 2022 Sep; 12(1):16247. PubMed ID: 36171401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis.
    Du H; Hou S; Zhang L; Liu C; Yu T; Zhang W
    Aging (Albany NY); 2023 May; 15(9):3759-3770. PubMed ID: 37166421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LINC01410 promotes cell proliferation and migration of cholangiocarcinoma through modulating miR-124-3p/SMAD5 axis.
    Jiang T; Wang C; Zhu Y; Han H
    J Gene Med; 2020 Jun; 22(6):e3162. PubMed ID: 31951299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA ROR1-AS1 enhances STC2-mediated cell growth and autophagy in cervical cancer through miR-670-3p.
    Zhang L; Wei Z; Wang Y; Xu F; Cheng Z
    J Recept Signal Transduct Res; 2021 Dec; 41(6):582-592. PubMed ID: 33081599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulated lncRNA Cyclin-dependent kinase inhibitor 2B antisense RNA 1 induces the proliferation and migration of colorectal cancer by miR-378b/CAPRIN2 axis.
    Zheng Y; Zeng J; Xia H; Wang X; Chen H; Huang L; Zeng C
    Bioengineered; 2021 Dec; 12(1):5476-5490. PubMed ID: 34511033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.